Authors: Rizzo, Stanislao; Barale, Pierre-Olivier; Ayello-Scheer, Sarah; Devenyi, Robert; Delyfer, Marie-Noëlle; Korobelnik, Jean-François; Rachitskaya, Aleksandra; Yuan, Alex; Jayasundera, K; Zacks, David; Handa, James; Montezuma, Sandra; Koozekanani, Dara; Stanga, Paulo; da Cruz, Lyndon; Walter, Peter; Augustin, Albert; Olmos de Koo, Lisa; Ho, Allen; Kirchhof, Bernd; Hahn, Paul; Vajzovic, Lejla; Iezzi, Raymond; Gaucher, David; Arevalo, J; Gregori, Ninel; Wiedemann, Peter; Özmert, Emin; Lim, Jennifer; Rezende, Flavio; Huang, Suber; Merlini, Francesco; Patel, Uday; Greenberg, Robert; Justus, Sally; Bacherini, Daniela; Cinelli, Laura; Humayun, Mark

Venue: British Journal of Ophthalmology

Type: Publication

Abstract: The Argus II retinal prosthesis (Second Sight Medical Products, Sylmar, CA, USA) is an electronic epiretinal implant designed for use in patients with end-stage retinitis pigmentosa, as well as for other outer retinal degenerative conditions, such as choroideremia, Leber’s congenital amaurosis, Bardet-Biedl syndrome, Usher syndrome and rod–cone disease.1 This device was tested in a clinical trial of 30 subjects in the USA and in Europe to measure the rate of serious adverse events (SAEs) and to assess its effects on functional vision and vi... (read more)

Impact:   3.109398E-9    2.4064535E-9    7    5  / Attention: 0 46

PubMed Id: 31300454